» Articles » PMID: 28389938

Combined Visual and Semi-quantitative Assessment of I-FP-CIT SPECT for the Diagnosis of Dopaminergic Neurodegenerative Diseases

Overview
Journal Neurol Sci
Specialty Neurology
Date 2017 Apr 9
PMID 28389938
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Visual and semi-quantitative assessments of I-FP-CIT single-photon emission computed tomography (SPECT) are useful for the diagnosis of dopaminergic neurodegenerative diseases (dNDD), including Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy, multiple system atrophy, and corticobasal degeneration. However, the diagnostic value of combined visual and semi-quantitative assessment in dNDD remains unclear. Among 239 consecutive patients with a newly diagnosed possible parkinsonian syndrome who underwent I-FP-CIT SPECT in our medical center, 114 patients with a disease duration less than 7 years were diagnosed as dNDD with the established criteria or as non-dNDD according to clinical judgment. We retrospectively examined their clinical characteristics and visual and semi-quantitative assessments of I-FP-CIT SPECT. The striatal binding ratio (SBR) was used as a semi-quantitative measure of I-FP-CIT SPECT. We calculated the sensitivity and specificity of visual assessment alone, semi-quantitative assessment alone, and combined visual and semi-quantitative assessment for the diagnosis of dNDD. SBR was correlated with visual assessment. Some dNDD patients with a normal visual assessment had an abnormal SBR, and vice versa. There was no statistically significant difference between sensitivity of the diagnosis with visual assessment alone and semi-quantitative assessment alone (91.2 vs. 86.8%, respectively, p = 0.29). Combined visual and semi-quantitative assessment demonstrated superior sensitivity (96.7%) to visual assessment (p = 0.03) or semi-quantitative assessment (p = 0.003) alone with equal specificity. Visual and semi-quantitative assessments of I-FP-CIT SPECT are helpful for the diagnosis of dNDD, and combined visual and semi-quantitative assessment shows superior sensitivity with equal specificity.

Citing Articles

Comparison of the ability of different quantitative indices in I-FP-CIT single-photon emission computed tomography to differentiate dopaminergic neurodegenerative disease.

Sato T, Sawai S, Shimada N Jpn J Radiol. 2024; 43(1):78-90.

PMID: 39235674 PMC: 11717878. DOI: 10.1007/s11604-024-01648-7.


A new quantitative index in the diagnosis of Parkinson syndrome by dopamine transporter single-photon emission computed tomography.

Bando R, Otsuka H, Otani T, Matsuda N, Azane S, Kunikane Y Ann Nucl Med. 2021; 35(4):504-513.

PMID: 33630226 DOI: 10.1007/s12149-021-01592-w.


Feasible Classified Models for Parkinson Disease from Tc-TRODAT-1 SPECT Imaging.

Hsu S, Lin H, Chen T, Du W, Hsu Y, Wu Y Sensors (Basel). 2019; 19(7).

PMID: 30978990 PMC: 6480576. DOI: 10.3390/s19071740.


Semi-quantitative dopamine transporter standardized uptake value in comparison with conventional specific binding ratio in [123I] FP-CIT single-photon emission computed tomography (DaTscan).

Wakabayashi Y, Takahashi R, Kanda T, Zeng F, Nogami M, Ishii K Neurol Sci. 2018; 39(8):1401-1407.

PMID: 29748936 DOI: 10.1007/s10072-018-3437-8.


Computer-aided diagnosis for (I)FP-CIT imaging: impact on clinical reporting.

Taylor J, Romanowski C, Lorenz E, Lo C, Bandmann O, Fenner J EJNMMI Res. 2018; 8(1):36.

PMID: 29740722 PMC: 5940985. DOI: 10.1186/s13550-018-0393-5.


References
1.
Hughes A, Daniel S, Kilford L, Lees A . Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992; 55(3):181-4. PMC: 1014720. DOI: 10.1136/jnnp.55.3.181. View

2.
Seret A, Nguyen D, Bernard C . Quantitative capabilities of four state-of-the-art SPECT-CT cameras. EJNMMI Res. 2012; 2(1):45. PMC: 3469367. DOI: 10.1186/2191-219X-2-45. View

3.
Piggott M, Marshall E, Thomas N, Lloyd S, Court J, Jaros E . Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain. 1999; 122 ( Pt 8):1449-68. DOI: 10.1093/brain/122.8.1449. View

4.
Gilman S, Wenning G, Low P, Brooks D, Mathias C, Trojanowski J . Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008; 71(9):670-6. PMC: 2676993. DOI: 10.1212/01.wnl.0000324625.00404.15. View

5.
Bajaj N, Hauser R, Grachev I . Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes. J Neurol Neurosurg Psychiatry. 2013; 84(11):1288-95. PMC: 3812862. DOI: 10.1136/jnnp-2012-304436. View